TSLA
Tesla
-- 437.012 NVDA
NVIDIA
-- 134.115 AMD
Advanced Micro Devices
-- 120.105 PLTR
Palantir
-- 78.620 QUBT
Quantum Computing
-- 17.945 
Teyi Pharmaceutical Group's low P/E ratio is seen as reasona...
Teyi Pharmaceutical Group's low P/E ratio is seen as reasonable given its expected underperformance and shrinking earnings outlook. Shareholders accept this, anticipating no pleasant surprises in future earnings. A strong share price rise seems unlikely under these conditions.
Improved Earnings Required Before Teyi Pharmaceutical Group Co.,Ltd (SZSE:002728) Stock's 29% Jump Looks Justified
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment